Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Arnold

Showing results (171-180 of 235) with videos related to

Pageof 24
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 12, 2013
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 studyEmmanouil Fokas, Lena Conradi, Christian Weiss, et al.
Cancers|April 12, 2022
A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal CancerPierfrancesco Franco, Eva Segelov, Anders Johnsson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2023
Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancerMichel Ducreux, Josep Tabernero, Axel Grothey, et al.
Oncology Research and Treatment|February 23, 2023
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany StudyFrancis Maren Konermann, Nele Gessler, Peter Wohlmuth, et al.
Journal of Clinical Medicine|September 10, 2021
Prognostic Impact of Acute Cardiovascular Events in COVID-19 Hospitalized Patients-Results from the CORONA Germany StudyMelanie A Gunawardene, Nele Gessler, Peter Wohlmuth, et al.
Clinical Colorectal Cancer|May 31, 2022
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer groupFrancesco Sclafani, Elisa Fontana, Lucjan Wyrwicz, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2018
Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trialSusanna Hegewisch-Becker, Stefanie Nöpel-Dünnebacke, Axel Hinke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancerClaus Rödel, Torsten Liersch, Robert Michael Hermann, et al.
European Journal of Cancer (Oxford, England : 1990)|February 11, 2023
Fast and label-free automated detection of microsatellite status in early colon cancer using artificial intelligence integrated infrared imagingKlaus Gerwert, Stephanie Schörner, Frederik Großerueschkamp, et al.
Zeitschrift Fur Gastroenterologie|June 17, 2020
[Prerequisites of magnetic resonance imaging for treatment planning in locally advanced rectal cancer - Interdisciplinary recommendations]Ulrike Attenberger, Claus Rödel, Michael Ghadimi, et al.
Pageof 24

Showing results (171-180 of 235) with videos related to

Sort By:
Pageof 24
International Journal of Radiation Oncology, Biology, Physics|November 12, 2013
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 studyEmmanouil Fokas, Lena Conradi, Christian Weiss, et al.
Cancers|April 12, 2022
A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal CancerPierfrancesco Franco, Eva Segelov, Anders Johnsson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2023
Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancerMichel Ducreux, Josep Tabernero, Axel Grothey, et al.
Oncology Research and Treatment|February 23, 2023
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany StudyFrancis Maren Konermann, Nele Gessler, Peter Wohlmuth, et al.
Journal of Clinical Medicine|September 10, 2021
Prognostic Impact of Acute Cardiovascular Events in COVID-19 Hospitalized Patients-Results from the CORONA Germany StudyMelanie A Gunawardene, Nele Gessler, Peter Wohlmuth, et al.
Clinical Colorectal Cancer|May 31, 2022
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer groupFrancesco Sclafani, Elisa Fontana, Lucjan Wyrwicz, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2018
Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trialSusanna Hegewisch-Becker, Stefanie Nöpel-Dünnebacke, Axel Hinke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancerClaus Rödel, Torsten Liersch, Robert Michael Hermann, et al.
European Journal of Cancer (Oxford, England : 1990)|February 11, 2023
Fast and label-free automated detection of microsatellite status in early colon cancer using artificial intelligence integrated infrared imagingKlaus Gerwert, Stephanie Schörner, Frederik Großerueschkamp, et al.
Zeitschrift Fur Gastroenterologie|June 17, 2020
[Prerequisites of magnetic resonance imaging for treatment planning in locally advanced rectal cancer - Interdisciplinary recommendations]Ulrike Attenberger, Claus Rödel, Michael Ghadimi, et al.
Pageof 24